ENDRA Life Sciences (NDRA) Long-Term Deferred Tax (2019 - 2023)

ENDRA Life Sciences (NDRA) has 4 years of Long-Term Deferred Tax data on file, last reported at $21.2 million in Q4 2023.

• Long-Term Deferred Tax for Q4 2023 came in at $21.2 million, up 14.2% year-over-year; the trailing twelve-month figure through Dec 2023 was $21.2 million (up 14.2% YoY), and the FY2023 annual result was $21.2 million, up 14.2% from the prior year.
• Long-Term Deferred Tax grew to $21.2 million in Q4 2023 per NDRA's latest filing, from $18.5 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $21.2 million in Q4 2023 and troughed at $7.8 million in Q4 2019.
• A 4-year average of $15.3 million and a median of $16.2 million in 2021 frame the typical range for Long-Term Deferred Tax.
• The sharpest annual moves came in 2022 and 2023: Long-Term Deferred Tax jumped 34.05% in 2022, then increased 14.2% in 2023.
• A 4-year view of Long-Term Deferred Tax shows it stood at $7.8 million in 2019, then jumped by 76.87% to $13.8 million in 2021, then surged by 34.05% to $18.5 million in 2022, then grew by 14.2% to $21.2 million in 2023.
• Business Quant data shows NDRA's Long-Term Deferred Tax at $21.2 million in Q4 2023, $18.5 million in Q4 2022, and $13.8 million in Q4 2021.